Literature DB >> 23425398

Nail psoriasis - a treatment challenge.

Marc A Radtke1, Florian C Beikert, Matthias Augustin.   

Abstract

Nail involvement in psoriasis is common and mostly occurs with other lesions but can also occur alone. Besides psychosocial and aesthetic impairments, patients often complain about functional impairment. Nail psoriasis is a predictor for more severe psoriasis, decreased quality of life, and a higher risk for the development of psoriatic arthritis. Onychomycosis and other differential diagnoses should be excluded prior to treatment. This article presents an overview of different clinical appearances of nail psoriasis, the essential diagnostic assessment before treatment, important differential diagnoses, and published data on treatment options for nail psoriasis.
© The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23425398     DOI: 10.1111/ddg.12054

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  10 in total

Review 1.  Secukinumab in the Treatment of Palmoplantar, Nail, Scalp, and Pustular Psoriasis.

Authors:  April W Armstrong; Ron Vender; Leon Kircik
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

2.  Patient-relevant needs and treatment goals in nail psoriasis.

Authors:  C Blome; A Costanzo; E Dauden; C Ferrandiz; G Girolomoni; R Gniadecki; L Iversen; A Menter; K Michaelis-Wittern; A Morita; H Nakagawa; K Reich; M Augustin
Journal:  Qual Life Res       Date:  2015-10-03       Impact factor: 4.147

3.  Pulsed-dye Laser Versus Intralesional Steroid in the Management of Nail Psoriasis: A Randomized, Intra-patient, Comparative, Controlled Study.

Authors:  Mona Soliman; Hanaa Abdel Aal; Ahmed M Sadek; Abeer Attia Tawfik
Journal:  J Clin Aesthet Dermatol       Date:  2021-09

Review 4.  [Psoriasis in special localizations].

Authors:  A Schmieder; W K Peitsch
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

Review 5.  Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery.

Authors:  Kevin Chen; Vinam Puri; Bozena Michniak-Kohn
Journal:  AAPS J       Date:  2021-01-13       Impact factor: 4.009

6.  Comparing the Efficacy of Triamcinolone Acetonide Iontophoresis versus Topical Calcipotriol/Betamethasone Dipropionate in Treating Nail Psoriasis: A Bilateral Controlled Clinical Trial.

Authors:  Nasrin Saki; Shahla Hosseinpoor; Alireza Heiran; Ali Mohammadi; Mehdi Zeraatpishe
Journal:  Dermatol Res Pract       Date:  2018-11-21

7.  Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial.

Authors:  B E Elewski; C S Baker; J J Crowley; Y Poulin; M M Okun; B Calimlim; Z Geng; O Reyes Servin; P A Rich
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-09-04       Impact factor: 6.166

8.  Efficacy of Biologics Targeting Tumour Necrosis Factor-alpha, Interleukin-17 -12/23, -23 and Small Molecules Targeting JAK and PDE4 in the Treatment of Nail Psoriasis: A Network Meta-analysis.

Authors:  Júlia Szebényi; Noémi Gede; Péter Hegyi; Zsolt Szakács; Margit Solymár; Bálint Erőss; András Garami; Kornélia Farkas; Dezső Csupor; Rolland Gyulai
Journal:  Acta Derm Venereol       Date:  2020-11-12       Impact factor: 3.875

9.  Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy.

Authors:  Georgios Kokolakis; Frank Bachmann; Kerstin Wolk; Robert Sabat; Sandra Philipp
Journal:  Acta Derm Venereol       Date:  2020-07-28       Impact factor: 3.875

10.  A Case of Nail Psoriasis Improved by Treatment with Golimumab in a Psoriatic Arthritis Patient.

Authors:  So Young Jung
Journal:  Ann Dermatol       Date:  2017-06-21       Impact factor: 1.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.